[1] LI XY, FENG JF.Treatment of primary central nervous system lymphoma[J]. Journal of International Oncology(国际肿瘤医学杂志), 2016, 43(1): 71-74. [2] YU Y, GAO XG.Progress in diagnosis and treatment of primary central nervous system lymphoma[J]. Chinese Journal of Cancer Prevention and Treatment(中华肿瘤防治杂志), 2019, 26(16): 1145-1149. [3] LI YJ, LIU YT, ZHOU H.Rituximab with high-dose methotrexate in primary central nervous system lymphoma[J]. The Journal of Evidence-Based Medicine(循证医学), 2018, 18(2): 78-82. [4] Chinese Society of Clinical Oncology, Anti Leukemla Alliance of Chinese Society of Clinical Oncology. Expert consensus on high dose methotrexate calcium folinate rescue therapy for malignant tumor[J]. Chinese Journal of Clinical Oncology(中国肿瘤临床), 2019, 46(15): 761-767. [5] Cancer Clinical Chemotherapy Committee of China Anti-cancer Association, Cancer Support Therapy Committee of China Anti-cancer Association. Chinese expert consensus on prevention and treatment of malignant vomiting related to tumor drug therapy(2014)[J]. Chinese Clinical Oncology(临床肿瘤学杂志), 2014, 19(3): 263-273. [6] Chinese Society of Clinical Oncology, Chinese Society of Hemato-logy, Oncologist Assessment Committee of Chinese Medical Association. Chinese expert consensus on prevention and treatment of HBV reactivation in lymphoma immunochemotherapy[J]. Chinese Clinical Oncology(临床肿瘤学杂志), 2013, 18(10): 935-942. [7] JIANG FL, SHI WJ, LUAN F, et al.Clinical research on HBV reactivation after TP chemotherapy in patients with gynecologic tumors with HBsAg(-) and HBcAb(+)[J]. China Modern Doctor(中国现代医生), 2016, 54(12): 81-84. [8] LI YJ, JIANG WQ, LI S, et al.A study to compare the pharmaco-dynamics and pharmacokinetics of two regimens of high-dose methotrexate in patients with lymphoma[J]. The Practical Journal of Cancer(实用癌症杂志), 2010, 25(2): 153-157. [9] XU WQ, TANG YM, FANG CQ, et al.Study on elimination delay in high dose methotrexate therapy in childhood acute lymphoblastic leukemia[J]. Chinese Journal of Hematology(中华血液学杂志), 2015, 26(1): 15-18. [10] ZHU TT, ZHAO YL, FENG LY, et al.Research progress on the influe-ncing factors and mechanism of elimination delay after high-dose methotrexate chemotherapy[J]. Pharmaceutical and Clinical Research(药学与临床研究), 2017, 25(1): 49-54. [11] LAI R, YANG RR.TDM of High dose methotrexate in the treatment of adult diffuse large B-cell lymphoma[J]. Chinese Journal of Clinical Rational Drug Use(临床合理用药), 2019, 12(10): 65-66. [12] HE HL, LI G, LI J, et al.Application of blood concentration monitoring in childhood acute lymphoblastic leukemia treated with high-dose methotrexate[J]. Practical Journal of Clinical Medicine(实用医院临床杂志), 2016, 9(3): 74-77. [13] WU W, YAO DF, XU Q.Clinical pharmacist’s involvement in treatment of delayed excretion of large doses of methotrexate in post-drug period: case analysis[J]. Evaluation and Analysis of Drug-Use in Hospitals of China(中国医院用药评价与分析), 2017, 14(8): 741-743. [14] HUANG L, XU YJ, FENG WY.Pharmaceutical practice of clinical pharmacists participating in rescue treatment of large dose methionine poisoning[J]. China Pharmacy(中国药房), 2016, 24(46): 4399-4401. |